Skip to main content

Advertisement

Log in

The clinical and laboratory features of patients with triple A syndrome: a single-center experience in Turkey

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Aim

Triple-A Syndrome (TAS) is a rare autosomal recessive disorder characterized by adrenal insufficiency, achalasia, and alacrimia. This disorder is caused by mutations in the AAAS gene. The aim of this study is to discuss the clinical, laboratory and molecular genetic analysis results of 12 patients with TAS.

Method

We evaluated 12 patients from 8 families. Clinical and laboratory data were retrospectively collected from the medical records of the patients in the database for the period 2015–2020. All exons and exon-intron junctions of the AAAS gene were evaluated by next-generation sequencing method. Detected variants were classified according to American Collage of Medical Genetics criteria.

Results

Alacrimia was found in all patients (100%); achalasia was found in 10 patients (83.3%) and adrenal insufficiency was found in 10 patients (83.3%). In addition, hyperreflexia(6/12), learning disability(5/12), hypernasal speech(5/12), muscle weakness(8/12), delayed walking(7/12), delayed speech(6/12), excessive sweating(7/12), optic atrophy(1/12), epilepsy(1/12), palmoplantar hyperkeratosis(5/12), multiple dental caries(9/12), atrophy of the thenar/hypothenar muscles(4/12) and short stature(4/12) were detected. The DHEA-S levels were measured in 10 patients and were found to be low in 8 of them. In all patients, the sodium and potassium levels were found to be normal. AAAS gene sequencing revealed four previously reported c.1066_1067del (p.Leu356fs*8), c.1432 C > T (p.Arg478*), c.688 C > T (p.Arg230*), and c.1368_1372del (p.Gln456fs*38) variants and two novel homozygous c.1250-1 G > A and c.398_399 + 2del variants in the AAAS gene.

Conclusion

We detected two novel variants in the AAAS gene. While the classic triad is present in 66.7% of the cases, neurological dysfunction, skin and dental pathologies also occur quite frequently. The earliest and most common finding of TAS is alacrimia. Therefore, adrenal insufficiency should be investigated in all patients with alacrimia and if necessary, genetic analysis should be performed for TAS. In addition, TAS should be followed up with a multidisciplinary approach since it involves many systems.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. D.C. Sadowski, F. Ackah, B. Jiang, L.W. Svenson, Achalasia: incidence, prevalence and survival. A population-based study. Neurogastroenterol. Motil. 22, 256–261 (2010). https://doi.org/10.1111/j.1365-2982.2010.01511.x. Epub 2010 May 11

    Article  Google Scholar 

  2. J. Allgrove, G.S. Clayden, J.C. Macaulay, Familial glucocorticoid deficiency with achalasia of the cardia and deficient tear production. Lancet 311, 1284–1286 (1978). https://doi.org/10.1016/S0140-6736(78)91268-0

    Article  Google Scholar 

  3. K. Handschug, S. Sperling, S.J. Yoon, S. Hennig, A.J. Clark, A. Huebner, Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. Hum. Mol. Genet 10, 283–290 (2001). https://doi.org/10.1093/hmg/10.3.283

    Article  CAS  Google Scholar 

  4. J.M. Cronshaw, A.N. Krutchinsky, W. Zhang, B.T. Chait, M.J. Matunis, Proteomic analysis of the mammalian nuclear pore complex. J. Cell Biol. 158, 915–927 (2002). https://doi.org/10.1083/jcb.200206106

    Article  CAS  Google Scholar 

  5. R. Prasad, L.A. Metherell, A.J. Clark, H.L. Storr, Deficiency of ALADIN impairs redox homeostasis in human adrenal cells and inhibits steroidogenesis. Endocrinology 154, 3209–3218 (2013). https://doi.org/10.1210/en.2013-1241

    Article  CAS  Google Scholar 

  6. R. Jühlen, J. Idkowiak, A.E. Taylor, et al. Role of ALADIN in human adrenocortical cells for oxidative stress response and steroidogenesis. PLoS ONE 10, e0124582 (2015). https://doi.org/10.1371/journal.pone.0124582

    Article  CAS  Google Scholar 

  7. F. Roucher-Boulez, A. Brac de la Perriere, A. Jacquez et al. Triple-A syndrome: a wide spectrum of adrenal dysfunction. Eur. J. Endocrinol. 178, 199–207 (2018)

    Article  CAS  Google Scholar 

  8. F. Kilicli, F. Acibucu, S. Senel et al. Allgrove syndrome. Singap. Med. J. 53, e92–4 (2012)

    Google Scholar 

  9. M. Ventura, J. Serra-Caetano, R. Cardoso, I. Dinis, M. Melo, F. Carrilho, A. Mirante, The spectrum of pediatric adrenal insufficiency: insights from 34 years of experience. J. Pediatr. Endocrinol. Metab. 32, 721–726 (2019)

    Article  Google Scholar 

  10. C.E. Flück, Mechanısms In Endocrınology: Update on pathogenesis of primary adrenal insufficiency: beyond steroid enzyme deficiency and autoimmune adrenal destruction. Eur. J. Endocrinol. 177, 99–111 (2017). Epub 2017 Apr 27

    Article  Google Scholar 

  11. R. Perry, O. Kecha, J. Paquette, C. Huot, G. Van Vliet, C. Deal, Primary adrenal insufficiency in children: twenty years experience at the Sainte-ustine Hospital, Montreal. J. Clin. Endocrinol. Metab. 90, 3243–3250 (2005). Epub 2005 Apr 5

    Article  CAS  Google Scholar 

  12. M. Wijaya, M. Huamei, Z. Jun, M. Du, Y. Li, Q. Chen, H. Chen, G. Song, Etiology of primary adrenal insufficiency in children: a 29-year singlecenter experience. J. Pediatr. Endocrinol. Metab. 32, 615–622 (2019)

    Article  CAS  Google Scholar 

  13. T. Kirkgoz, T. Guran, Primary adrenal insufficiency in children: diagnosis and management. Best. Pr. Res Clin. Endocrinol. Metab. 32, 397–424 (2018). https://doi.org/10.1016/j.beem.2018.05.010

    Article  CAS  Google Scholar 

  14. E. Kurnaz, P. Duminuco, Z. Aycan, Ş. Savaş-Erdeve, N. Muratoğlu Şahin, M. Keskin, E. Bayramoğlu, M. Bonomi, S. Çetinkaya, Clinical and genetic characterisation of a series of patients with triple A syndrome. Eur. J. Pediatr. 177(3 Mar), 363–369 (2018). https://doi.org/10.1007/s00431-017-3068-8. Epub 2017 Dec 19

    Article  CAS  Google Scholar 

  15. R. Polat, A. Ustyol, E. Tuncez, T. Guran, A broad range of symptoms in allgrove syndrome: single center experience in Southeast Anatolia. J. Endocrinol. Investig. 43(2 Feb), 185–196 (2020). https://doi.org/10.1007/s40618-019-01099-2. Epub 2019 Aug 21

    Article  CAS  Google Scholar 

  16. T. Milenkovic, D. Zdravkovic, N. Savic, S. Todorovic, K. Mitrovic, K. Koehler, A. Huebner, Triple A syndrome: 32 years experience of a single centre (1977-2008). Eur. J. Pediatr. 169(11), 1323–8 (2010). https://doi.org/10.1007/s00431-010-1222-7. Epub 2010 May 25

    Article  Google Scholar 

  17. F. Gaiani, P. Gismondi, R. Minelli, G. Casadio, N. de’Angelis, F. Fornaroli, G.L. de’Angelis, M. Manfredi, Case report of a familial triple: a syndrome and review of the literature. Med. (Baltim.) 29(22), e20474 (2020). https://doi.org/10.1097/MD.0000000000020474. 99

    Article  Google Scholar 

  18. F. Kallabi, N. Belghuith, H. Aloulou et al. Clinical and genetic characterization of 26 Tunisian patients with Allgrove syndrome. Arch. Med. Res. 47, 105–110 (2016). https://doi.org/10.1016/j.arcmed.2016.04.004

    Article  CAS  Google Scholar 

  19. L.M. Walter, E.F. Christa. Adrenal cortex and its disorders. Pediatric Endocrinology. In: ed A. Sperling Mark (Elsevier Saunders: Philadelphia, 2014), p. 471–532.

  20. H. Patt, K. Koehler, S. Lodha et al. Phenotype–genotype spectrum of AAA syndrome from Western India and systematic review of literature. Endocr. Connect. 6, 901–913 (2017). https://doi.org/10.1530/EC-17-0255

    Article  CAS  Google Scholar 

  21. H.L. Storr, B. Kind, D.A. Parfitt et al. Deficiency of ferritin heavy-chain nuclear import in triple a syndrome implies nuclear oxidative damage as the primary disease mechanism. Mol. Endocrinol. 23, 2086–2094 (2009). https://doi.org/10.1210/me.2009-0056

    Article  CAS  Google Scholar 

  22. M. Hirano, Y. Furiya, H. Asai, A. Yasui, S. Ueno, ALADINI482S causes selective failure of nuclear protein import and hypersensitivity to oxidative stress in triple A syndrome. Proc. Natl Acad. Sci. 103, 2298–2303 (2006). https://doi.org/10.1073/pnas.0505598103

    Article  CAS  Google Scholar 

  23. E. Çamtosun, İ. Dündar, A. Akıncı, L. Kayaş, N. Çiftci, Pediatric Primary Adrenal Insufficiency: A 21-year Single Center Experience. J. Clin. Res Pediatr. Endocrinol. 13(1 Feb), 88–99 (2021). https://doi.org/10.4274/jcrpe.galenos.2020.2020.0132. Epub 2020 Sep 17

    Article  Google Scholar 

  24. R. Lanes, L.P. Plotnick, T.E. Bynum et al. Glucocorticoid and partial mineralocorticoid deficiency associated with achalasia. J. Clin. Endocrinol. Metab. 50, 268–270 (1980). https://doi.org/10.1210/jcem-50-2-268

    Article  CAS  Google Scholar 

  25. C.V. Collares, J. Antunes-Rodrigues, A.C. Moreira, S.N. Franca, L.A. Pereira, M.M. Soares, J. Elias Junior, A.J. Clark, M. de Castro, L.L. Elias, Heterogeneity in the molecular basis of ACTH resistance syndrome. Eur. J. Endocrinol. 159, 61–68 (2008). https://doi.org/10.1530/EJE-08-0079

    Article  CAS  Google Scholar 

  26. M. Dumic, N. Barišic, V. Kusec, K. Stingl, M. Skegro, A. Stanimirovic, K. Koehler, A. Huebner, Long-term clinical follow-up and molecular genetic findings in eight patients with triple A syndrome. Eur. J. Pediatr. 171(10), 1453–9 (2012). https://doi.org/10.1007/s00431-012-1745-1. Epub 2012 Apr 28

    Article  CAS  Google Scholar 

  27. A. Tebaibia, M.A. Boudjella, D. Boutarene, F. Benmediouni, H. Brahimi, N. Oumnia, Incidence, clinical features and para-clinical findings of achalasia in Algeria: experience of 25 years. World J. Gastroenterol. 22, 8615–8623 (2016). https://doi.org/10.3748/wjg.v22.i38.8615

    Article  Google Scholar 

  28. C. Hallal, C.O. Kieling, D.L. Nunes, C.T. Ferreira, G. Peterson, S.G. Barros, C.A. Arruda, J.C. Fraga, H.A. Goldani, Diagnosis, misdiagnosis, and associated diseases of achalasia in children and adolescents: a twelve-year single center experience. Pediatr. Surg. Int. 28(12), 1211–1217 (2012). https://doi.org/10.1007/s00383-012-3214-3

    Article  Google Scholar 

  29. A.E. Vallet, A. Verschueren, P. Petiot et al. Neurological features in adult Triple-A (Allgrove) syndrome. J. Neurol. 259, 39–46 (2012). https://doi.org/10.1007/s00415-011-6115-9

    Article  Google Scholar 

  30. C. Goizet, B. Catargi, F. Tison, A. Tullio-Pelet, S. Hadj-Rabia, F. Pujol, A. Lagueny, S. Lyonnet, D. Lacombe, Progressive bulbospinal amyotrophy in triple A syndrome with AAAS gene mutation. Neurology 58(6), 962–965 (2002)

    Article  CAS  Google Scholar 

  31. H. Houlden, S. Smith, M. De Carvalho, J. Blake, C. Mathias, N.W. Wood, M.M. Reilly, Clinical and genetic characterization of families with triple A (Allgrove) syndrome. Brain 125(Pt 12 Dec), 2681–90 (2002). https://doi.org/10.1093/brain/awf270

    Article  Google Scholar 

  32. M. Gazarian, C.T. Cowell, M. Bonney, W.G. Grigor, The 4A syndrome: adrenocortical insufficiency associated with achalasia, alacrima, autonomic and other neurological abnormalities. Eur. J. Pediatr. 154, 18–23 (1995)

    Article  CAS  Google Scholar 

  33. B. Kind, K. Koehler, M. Krumbholz, D. Landgraf, A. Huebner, Intracellular ROS level is increased in fibroblasts of triple A syndrome patients. J. Mol. Med (Berl.) 88, 1233–1242 (2010). https://doi.org/10.1007/s00109-010-0661-y

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ruken Yıldırım.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Ethical approval

The study was performed in accordance with the rules of Declaration of Helsinki and approved by the Institutional Ethics Committee of Gazi Yaşargil Training and Research Hospital (Document number: 22.07.2022/142).

Informed consent

Since the study was retrospective, informed consent was not available from the parents of the patients.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yıldırım, R., Unal, E., Tekmenuray-Unal, A. et al. The clinical and laboratory features of patients with triple A syndrome: a single-center experience in Turkey. Endocrine 79, 376–383 (2023). https://doi.org/10.1007/s12020-022-03206-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-022-03206-5

Keywords

Navigation